A biopharmaceutical company developing novel vaccines & therapeutic proteins in plants to address a broad range of infectious diseases worldwide; especially coronavirus, influenza and rotavirus. Committed to providing highly effective & competitive vaccines & therapeutic proteins based on proprietary VLP & manufacturing technologies. Leader in the development of VLP vaccines using a transient expression system that produces recombinant vaccine antigents in plants. Medicago has a Covid-19 vaccine in clinical trials.